DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2147506): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: The budget was changed) |
||||||
Property / budget | |||||||
178,156.84 Euro
| |||||||
Property / budget: 178,156.84 Euro / rank | |||||||
Normal rank | |||||||
Property / EU contribution | |||||||
129,222.34 Euro
| |||||||
Property / EU contribution: 129,222.34 Euro / rank | |||||||
Normal rank | |||||||
Property / co-financing rate | |||||||
72.53 percent
| |||||||
Property / co-financing rate: 72.53 percent / rank | |||||||
Normal rank |
Revision as of 02:29, 11 February 2022
Project Q2147506 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX |
Project Q2147506 in Italy |
Statements
129,222.34 Euro
0 references
178,156.84 Euro
0 references
72.53 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
UNISALERNO- DIFARMA
0 references
BIOTECNOLOGIE (Italian)
0 references
BIOTECHNOLOGY (English)
0 references
BARONISSI
0 references
Identifiers
B48I17000350008
0 references